Addressing opioid use disorder through treatment centers instead of prisons

Addressing opioid use disorder through treatment centers instead of prisons
Bottom of the article

Local people with local solutions — that’s what we’re all about at Healthy Communities News. In this episode, our host, Hilary Russo, travels to Virginia and North Carolina to check out two communities taking creative approaches to address opioid use disorder. We’ll hear about these innovative solutions from the folks on the ground putting them into action and get a glimpse into recovery from Wanda Jenkins, who is using her experience with opioid use disorder to help others.


A helping hand from someone who’s been there: Gina’s story

In this episode’s podcast, we meet Gina Musa, who advocates passionately for community members in rural North Carolina struggling with opioid use disorder. A former sex worker, Gina draws on her own experience with addiction and recovery to connect people with much-needed resources and support. Today, she is a Linkage to Care Coordinator for the North Carolina Harm Reduction Coalition, a job funded by an Aetna Foundation grant.

Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
0
Display Hero
Off
Assets
CSR Pillars
Audience
Narrative themes

CVS Health combines “Guardian Angel” and Unite Us programs to support opioid overdose victims in North Carolina

CVS Health combines “Guardian Angel” and Unite Us programs to support opioid overdose victims in North Carolina
Top of the article

Collaboration with Unite Us also expanded to serve vulnerable community members in New Orleans and Tampa Bay

WOONSOCKET, R.I. — According to the Centers for Disease Control and Prevention (CDC), more than 130 people die every day from opioid overdoses. For those individuals who suffer an overdose and are fortunate enough to survive, the event can serve as a turning point on the road to recovery.

To help people when they are potentially the most open to treatment, CVS Health (NYSE: CVS) is enhancing the "Guardian Angel" program, which is designed to help individuals who suffer an opioid-related overdose. In North Carolina, the Guardian Angel program will now be supported by CVS Health's collaboration with Unite Us, a leading social care coordination platform. Through this combination, clinical case managers can use the Unite Us network of social services to connect individuals with non-clinical support that can aid their recovery, such as community resources to help with housing, food insecurity and financial assistance.

"The Guardian Angel program already has a high engagement rate of about 50 percent because it connects with people in a compassionate way during the time when they need it most," said Dr. Daniel Knecht, Vice President, Health Strategy and Innovation, CVS Health. "We recognize that whether a person is successfully able to fight addiction is not solely determined by the medical treatment that they receive. Through the Unite Us network of social care providers, people can more easily access support within their community and have a better chance of recovery."

Since the Guardian Angel program was launched by Aetna, a CVS Health company, in 2018, clinical case managers have connected with nearly 1,000 Aetna members who have suffered an overdose as well as their families, providing education and resources around the effectiveness of evidence-based addiction treatment. Members who have been contacted live in every part of the country and range in age from 16 to 79 years old (with an average age of 45).

The clinical case managers that participate in the Guardian Angel program will also be a part of the NCCARE360 network in North Carolina. NCCARE360 is the first statewide network that unites health care and human services organizations with a shared technology, Unite Us, that enables a coordinated, community-oriented, person-centered approach for delivering care. NCCARE360 is planned to be available statewide in North Carolina by the end of 2020.

Helping improve community health in New Orleans and Tampa Bay

In addition to integrating the Guardian Angel and Unite Us programs in North Carolina, CVS Health and Unite Us also launched programs in New Orleans and Tampa Bay, Florida to help Aetna's Medicaid and Dual Eligible (people eligible for both Medicaid and Medicare) members more easily access social services within their community. Working with Unite Us, Aetna's Dual-Eligible Special Needs Plan (DSNP) members in these communities can receive help from a wide range of services through local organizations - transportation, food assistance and meal delivery, adult day care, employment services and housing support, among others.

"Improving health starts at the community level, and most of that work needs to take place outside of a doctor's office," said Dr. Garth Graham, Vice President, Community Health & Impact, CVS Health. "Our collaboration with Unite Us allows us to support some of the most vulnerable members of the community, providing them with the local resources that they need to improve their everyday lives."

CVS Health's continued work with Unite Us is a key component of Destination: Health, a series of business programs focused on helping people improve their health outside of a clinical setting.

"We're excited and inspired by the progress and impact of the Destination Health initiative as it expands through the country," says Taylor Justice, Co-Founder and President of Unite Us. "It is encouraging to see the local community support as our teams continue to launch networks in Tampa and New Orleans to support Aetna's DSNP members, as well as combining the Guardian Angel and Unite Us programs in North Carolina."

About CVS Health

CVS Health employees are united around a common goal of becoming the most consumer-centric health company in the world. We're evolving based on changing consumer needs and meeting people where they are, whether that's in the community at one of our nearly 10,000 local touchpoints, in the home, or in the palm of their hand. Our newest offerings from HealthHUB locations that are redefining what a pharmacy can be, to innovative programs that help manage chronic conditions are designed to create a higher-quality, simpler and more affordable experience. Learn more about how we're transforming health at http://www.cvshealth.com.

Media contact

Ethan Slavin
860-273-6095
SlavinE@aetna.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
2
Display Hero
Off
Campaign
CSR Pillars
Audience

CVS Health Completes Rollout of Time Delay Safes in All of Its Virginia Pharmacies

Top of the article

New safes for controlled substances anticipated to help reduce robbery incidents

All 353 CVS Pharmacy locations in the state now using time-delay safe technology

WOONSOCKET, R.I. CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced today that it has completed the rollout of time delay safes in all of its 353 CVS Pharmacy locations in Virginia, including pharmacies located in Target stores. The safes are anticipated to help prevent pharmacy robberies and the diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals. In addition, the safes are anticipated to help CVS Pharmacy ensure the safety and well-being of its customers and employees.

CVS Pharmacy expects these time delay safes to help deter pharmacy robberies including those involving opioid medications such as oxycodone and hydrocodone by electronically delaying the time it takes for pharmacy employees to be able to open the safe. CVS Pharmacy first implemented time delay safes in Indianapolis, a city experiencing at the time a high volume of pharmacy robberies, in 2015. The company saw a 70 percent decline in pharmacy robberies among the Indianapolis stores where the time delay safes had been installed.

"Pharmacy robberies are a challenging issue for every pharmacy and we are committed to doing all we can to reduce the number of incidents in our Virginia stores," said Dick Dakessian, Division Leader for CVS Pharmacy. "We have seen that time delay safes, combined with other security policies and procedures in place at our stores, can greatly reduce these incidents and are pleased to roll out this enhanced security measure. These safes will help ensure that our pharmacies remain a safe environment for our patients and colleagues."

The time delay function cannot be overridden and is designed to serve as a deterrent to would-be pharmacy robbers whose goal is to enter and exit their robbery targets as quickly as possible. All CVS Pharmacy locations with time delay safes display visible signage warning that time delay safes are in use to prevent on-demand access to controlled substance narcotics.

CVS Health's time delay safe program is one of many company initiatives to help address and prevent prescription opioid misuse, diversion and abuse.

The company, for example, has expanded its Safe Medication Disposal Program in Virginia, completing the installation of 72 drug disposal kiosks in select CVS Pharmacy locations in communities across the state, adding to the 78 units previously donated to local law enforcement.

In 2020, the company will add 1,000 in-store safe medication disposal units to the more than 1,800 units currently in CVS Pharmacy locations nationwide. It will also donate up to 400 additional units to local police departments, in addition to the 1,000 units already donated to law enforcement. Together, the existing medication disposal units have collected more than 1.1 million pounds of unwanted or expired medications, including 66,600 pounds in Virginia.

Additionally, beginning next year, all CVS Pharmacy locations that do not offer a safe medication disposal kiosk will begin to offer DisposeRx packets at no cost to patients filling an opioid prescription for the first time. According to the manufacturer, when water and the DisposeRx powder are added to a pill bottle with unwanted prescription medications, the combination produces a biodegradable gel, allowing for safe disposal at home.

CVS Health's commitment to helping prevent and address prescription drug misuse also extends to community education and increasing access to the opioid overdose-reversal drug naloxone.

The company is collaborating with Discovery Education, tapping into their expertise in digital curriculum and content, to enhance CVS Health's prescription drug abuse prevention education program, Pharmacists Teach. The program, which has already reached more than 500,000 students and parents across the country, will aim to reach an additional 1.4 million people over three years following this investment.

Finally, CVS Pharmacy patients can now access the opioid overdose-reversal drug naloxone without an individual prescription at every CVS Pharmacy location nationwide, including all 50 states, Washington, D.C., and Puerto Rico. CVS Health has also worked with Google to help people locate naloxone at CVS Pharmacy and other locations in their local community using Google's locator tool.

To learn more about CVS Health's efforts to combat prescription drug misuse, visit our website.

About CVS Pharmacy

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Joe Goode
401-770-9820
Joseph.Goode@CVSHealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
Off
CSR Pillars
Locations
Audience

CVS Health Announces $750K in New Funding for California Harm Reduction Coalition

Top of the article

Three-year partnership will help support critical resources to address prescription opioid abuse across the state

OAKLAND, Calif. As part of its commitment to building healthier communities, CVS Health (NYSE: CVS) today announced it will be providing $750,000 over the next three years to the national Harm Reduction Coalition to improve the health and wellness of California residents impacted by prescription opioid misuse and abuse.

Harm Reduction Coalition, or HRC, is a national capacity-building and advocacy organization that promotes the health and dignity of individuals and communities affected by drug abuse and drug-related policies and provides a critical voice for those in the most vulnerable communities. The new funding from CVS Health will help support HRC as they tackle critical health issues faced by the California community related to prescription opioid misuse and abuse.

"We can help improve the health outcomes of our communities by strengthening our local support and empowering local organizations that are developing innovative solutions," said Kristen Miranda, California Market President for Aetna, a CVS Health company. "We know that so many communities across the country including in California have been impacted by widespread prescription opioid misuse and abuse. Our work with the HRC will support their efforts to address several elements of this significant public health issue in California and help local residents on their path to better health."

The funding will support HRC's Community Engagement Network to Expand Resources (CENTER) Initiative a three-year, state-wide effort designed to expand, develop and deepen harm reduction services throughout California. CENTER will be focused on convening diverse stakeholders to address drug-related stigmas, supporting syringe services programs with training and technical assistance, hosting state and national conferences and developing culturally relevant resources as a means to be better equipped to respond to the needs of people who misuse and abuse prescription drugs, their families, and impacted communities in California.

The CVS Health grant will be highlighted at a Harm Reduction Coalition training event and discussion taking place December 11 and 12 at the University of California, Fresno Center. The event is open to community members and service providers in the Central Valley that are focused on evidence-based strategies to address issues related to prescription opioid misuse and abuse.

"We have over 25 years of experience preventing overdose and drug-related harms through resources and education that are rooted in evidence and compassion," said Dr. Taeko Frost, Senior Director of Innovation and Strategy for Harm Reduction Coalition. "We know that harm reduction programs have been operating on shoestring budgets for years, only reaching the people most at risk of overdose. The CENTER Initiative will allow us to strengthen those programs through training and capacity-building, to build partnerships with other local programs, including health care providers and drug treatment access points, and to create a comprehensive statewide network for providers who can meaningfully engage with at-risk community members."

Building Healthier Communities by Addressing Prescription Opioid Misuse and Abuse

The grant is part of CVS Health's Building Healthier Communities initiative, which is a commitment to making community health and wellness central to the newly combined company's charge for a better world. Through Building Healthier Communities, CVS Health and its charitable foundations will support a range of initiatives and non-profit organizations across three categories: improving local access to affordable quality care; impacting public health challenges; and partnering with local communities.

One of the primary public health issues the company is addressing is the impact of the misuse and abuse of prescription opioids in communities around the country. CVS Health and Aetna's expansive reach, expertise and access to local communities position us to help fight prescription opioid abuse for the people we serve. Our comprehensive strategy focused on prevention, intervention and support, builds on years of innovative programs and allows us to identify new opportunities for impact. The company has made an enterprise-wide commitment to help address the inappropriate use of prescription opioids by designing programs that increase access to safe medication disposal, encourage appropriate utilization, educate patients at the pharmacy and teens and parents in communities, expand access to life-saving antidotes, work with providers to ensure they are following evidence-based opioid prescribing guidelines, and support local recovery programs.

This grant is part of CVS Health's commitment to investing in California's health care delivery system, reflected in the November 2018 agreement between CVS Health and California's Department of Managed Health Care (DMHC).

About Harm Reduction Coalition

Harm Reduction Coalition is a national advocacy and capacity-building organization that promotes the health and dignity of individuals and communities impacted by drug use. Our efforts advance harm reduction policies, practices and programs that address the adverse effects of drug use including overdose, HIV, hepatitis C, addiction, and incarceration. Recognizing that social inequality and injustice magnify drug-related harm and limit the voice of our most vulnerable communities, we work to uphold every individual's right to health and well-being and their competence to participate in the public policy dialogue.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Ethan Slavin
860-273-6095
SlavinE@aetna.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0
Display Hero
Off
CSR Pillars
Locations
Audience

CVS Health Launches Transform Oncology Care Program to Help Improve Patient Outcomes and Lower Overall Costs

Top of the article

New precision medicine strategy uses the latest genomics science and technology to help providers identify and start their patients on the best cancer treatment, faster

Comprehensive oncology management program includes enterprise capabilities to help address significant challenges at every point of the cancer care journey

WOONSOCKET, R.I. CVS Health (NYSE: CVS) today announced Transform Oncology Care , anchored on a first-of-its-kind precision medicine strategy for payors. The program uses genomic testing results at the point-of-prescribing to help patients start on the best treatment, faster and in addition, matches eligible patients to clinical trials. Transform Oncology Care also uses the Company's local footprint and unique assets to improve patient outcomes and lower overall costs at every point of the cancer care journey.

"Timing in cancer care is everything and when a patient does not get started on the right treatment it can result in progression and higher costs," said Alan Lotvin, M.D., Executive Vice President and Chief Transformation Officer, CVS Health. "We are the first company working to make the latest in precision medicine accessible to more patients and further empower informed treatment decision-making based on a patient's genetic profile to give them the best chance for successful treatment and improved quality-of-life."

Connecting Guidelines to Genetic Testing for the Best Treatment, Faster

The innovative precision medicine strategy, delivered in close coordination with oncologists, uses results of broad-panel gene sequencing tests and the latest National Comprehensive Cancer Network (NCCN) treatment and supportive care guidelines to help oncologists identify and start their patients on the most precise, appropriate treatment regimen based on their clinical and genetic profiles. Therapeutic regimens that align to NCCN guidelines, including those matched with the results of the broad-panel gene sequencing tests, will automatically receive prior authorization approval, speeding time to start of the therapy for patients. The strategy is enabled by an innovative collaboration with Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.

"CVS Health is making great strides in advancing patient care, and we are thrilled to contribute the benefits of genomic testing to these efforts," said Ryan Fukushima, Chief Operating Officer of Tempus. "We believe this collaboration has real potential to personalize treatment for patients while also reducing the total cost of care."

Today, the majority of cancers when diagnosed early can be effectively managed, treated or even cured.https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf For patients diagnosed with late-stage cancers, however, many can benefit from advanced genomic testing, yet very few eligible patients receive this type of testing today. This can inhibit the start of the most appropriate treatment and result in cancer progression and higher costs. For these patients, a web-based provider portal, built into the e-prescribing workflow, informs oncologists of the availability of Tempus' broad-panel gene sequencing tests at diagnosis, which are more comprehensive than the single-gene tests that are used today. The broad-panel tests identify a patient's genomic variants and the therapeutic options specific to their molecular and clinical profile. The testing results also match and help support the rapid enrollment of eligible patients in local clinical trials through Tempus' proprietary platform, facilitating broader access to experimental therapies. In addition, the portal provides oncologists real-time access to the latest NCCN guidelines at the point-of-prescribing.

The program includes CVS Health nurse-led care management, integrated with payor's existing programs, to create a more personalized experience for patients and their caregivers and close existing gaps in care. In addition, payors can adopt value-based contracts that employ provider networks to drive high-quality care and lower costs. Transform Oncology Care also uses the CVS Health's accessible, local footprint, connected data and integrated systems to help better identify and intervene with patients who could benefit from preventive or screening services.

Transform Oncology Care is available to other health plans. Aetna has adopted the program for fully insured commercial populations and is rolling it out with participating Aetna provider networks in 12 states.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Christina Beckerman
401-770-8868
Christina.Beckerman@cvshealth.com

Investor Contact

Valerie Haertel
401-770-4050
Valerie.Haertel@cvshealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
11
Display Hero
Off
Audience

CVS Health Completes Rollout of Time Delay Safes in All of Its West Virginia Pharmacies

Top of the article

New safes for controlled substances anticipated to help reduce robbery incidents

All 58 CVS Pharmacy locations in the state now using time-delay safe technology

WOONSOCKET, R.I. CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced today that it has completed the rollout of time delay safes in all of its 58 CVS Pharmacy locations in West Virginia, including pharmacies located in Target stores. The safes are anticipated to help prevent pharmacy robberies and the diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals. In addition, the safes are anticipated to help CVS Pharmacy ensure the safety and well-being of its customers and employees.

CVS Pharmacy expects these time delay safes to help deter pharmacy robberies including those involving opioid medications such as oxycodone and hydrocodone by electronically delaying the time it takes for pharmacy employees to be able to open the safe. CVS Pharmacy first implemented time delay safes in Indianapolis, a city experiencing at the time a high volume of pharmacy robberies, in 2015. The company saw a 70 percent decline in pharmacy robberies among the Indianapolis stores where the time delay safes had been installed.

"Pharmacy robberies are a challenging issue for every pharmacy and we are committed to doing all we can to reduce the number of incidents in our West Virginia stores," said Dick Dakessian, Division Leader for CVS Pharmacy. "We have seen that time delay safes, combined with other security policies and procedures in place at our stores, can greatly reduce these incidents and are pleased to roll out this enhanced security measure. These safes will help ensure that our pharmacies remain a safe environment for our patients and colleagues."

The time delay function cannot be overridden and is designed to serve as a deterrent to would-be pharmacy robbers whose goal is to enter and exit their robbery targets as quickly as possible. All CVS Pharmacy locations with time delay safes display visible signage warning that time delay safes are in use to prevent on-demand access to controlled substance narcotics.

CVS Health's time delay safe program is one of many company initiatives to help address and prevent prescription opioid misuse, diversion and abuse.

The company, for example, has expanded its Safe Medication Disposal Program in West Virginia, completing the installation of 27 drug disposal kiosks in select CVS Pharmacy locations in communities across the state, adding to the five units previously donated to local law enforcement.

In 2020, the company will add 1,000 in-store safe medication disposal units to the more than 1,800 units currently in CVS Pharmacy locations nationwide. It will also donate up to 400 additional units to local police departments, in addition to the 1000 units already donated to law enforcement. Together, the existing medication disposal units have collected more than 1.1 million pounds of unwanted or expired medications, including 7,600 pounds in West Virginia.

Additionally, beginning next year, all CVS Pharmacy locations that do not offer a safe medication disposal kiosk will begin to offer DisposeRx packets at no cost to patients filling an opioid prescription for the first time. According to the manufacturer, when water and the DisposeRx powder are added to a pill bottle with unwanted prescription medications, the combination produces a biodegradable gel, allowing for safe disposal at home.

CVS Health's commitment to helping prevent and address prescription drug misuse also extends to community education and increasing access to the opioid overdose-reversal drug naloxone.

The company is collaborating with Discovery Education, tapping into their expertise in digital curriculum and content, to enhance CVS Health's prescription drug abuse prevention education program, Pharmacists Teach. The program, which has already reached more than 500,000 students and parents across the country, will aim to reach an additional 1.4 million people over three years following this investment.

Finally, CVS Pharmacy patients can now access the opioid overdose-reversal drug naloxone without an individual prescription at every CVS Pharmacy location nationwide, including all 50 states, Washington, D.C., and Puerto Rico. CVS Health has also worked with Google to help people locate naloxone at CVS Pharmacy and other locations in their local community using Google's locator tool.

To learn more about CVS Health's efforts to combat prescription drug misuse, visit our website.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Joe Goode
401-770-9820
Joseph.Goode@CVSHealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
Off
CSR Pillars
Locations
Audience

CVS Health Completes Rollout of Time Delay Safes in All of Its North Carolina Pharmacies

Top of the article

New safes for controlled substances anticipated to help reduce robbery incidents

All 375 CVS Pharmacy locations in the state now using time-delay safe technology

WOONSOCKET, R.I. CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced today that it has completed the rollout of time delay safes in all of its 375 CVS Pharmacy locations in North Carolina, including pharmacies located in Target stores. The safes are anticipated to help prevent pharmacy robberies and the diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals. In addition, the safes are anticipated to help CVS Pharmacy ensure the safety and well-being of its customers and employees.

CVS Pharmacy expects these time delay safes to help deter pharmacy robberies including those involving opioid medications such as oxycodone and hydrocodone by electronically delaying the time it takes for pharmacy employees to be able to open the safe. CVS Pharmacy first implemented time delay safes in Indianapolis, a city experiencing at the time a high volume of pharmacy robberies, in 2015. The company saw a 70 percent decline in pharmacy robberies among the Indianapolis stores where the time delay safes had been installed.

"Pharmacy robberies are a challenging issue for every pharmacy and we are committed to doing all we can to reduce the number of incidents in our North Carolina stores," said Brian Bosnic, Division Leader for CVS. "We have seen that time delay safes, combined with other security policies and procedures in place at our stores, can greatly reduce these incidents and are pleased to roll out this enhanced security measure. These safes will help ensure that our pharmacies remain a safe environment for our patients and colleagues."

The time delay function cannot be overridden and is designed to serve as a deterrent to would-be pharmacy robbers whose goal is to enter and exit their robbery targets as quickly as possible. All CVS Pharmacy locations with time delay safes display visible signage warning that time delay safes are in use to prevent on-demand access to controlled substance narcotics.

CVS Health's time delay safe program is one of many company initiatives to help address and prevent prescription opioid misuse, diversion and abuse.

The company, for example, has expanded its Safe Medication Disposal Program in North Carolina, completing the installation of 65 drug disposal kiosks in select CVS Pharmacy locations in communities across the state, adding to the 42 units previously donated to local law enforcement.

In 2020, the company will add 1,000 in-store safe medication disposal units to the more than 1,800 units currently in CVS Pharmacy locations nationwide. It will also donate up to 400 additional units to local police departments, in addition to the 1000 units already donated to law enforcement. Together, the existing medication disposal units have collected more than 1.1 million pounds of unwanted or expired medications, including 47,000 pounds in North Carolina.

Additionally, beginning next year, all CVS Pharmacy locations that do not offer a safe medication disposal kiosk will begin to offer DisposeRx packets at no cost to patients filling an opioid prescription for the first time. According to the manufacturer, when water and the DisposeRx powder are added to a pill bottle with unwanted prescription medications, the combination produces a biodegradable gel, allowing for safe disposal at home.

CVS Health's commitment to helping prevent and address prescription drug misuse also extends to community education and increasing access to the opioid overdose-reversal drug naloxone.

The company is collaborating with Discovery Education, tapping into their expertise in digital curriculum and content, to enhance CVS Health's prescription drug abuse prevention education program, Pharmacists Teach. The program, which has already reached more than 500,000 students and parents across the country, will aim to reach an additional 1.4 million people over three years following this investment.

Finally, CVS Pharmacy patients can now access the opioid overdose-reversal drug naloxone without an individual prescription at every CVS Pharmacy location nationwide, including all 50 states, Washington, D.C., and Puerto Rico. CVS Health has also worked with Google to help people locate naloxone at CVS Pharmacy and other locations in their local community using Google's locator tool.

To learn more about CVS Health's efforts to combat prescription drug misuse, visit our website.

About CVS Pharmacy

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contacts

Joe Goode
401-770-9820
Joseph.Goode@CVSHealth.com

Brent Burkhardt
410-299-2528
bburkhardt@tbc.us

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
Off
CSR Pillars
Locations
Audience

CVS Health Expands Safe Medication Disposal Program in Ohio, Giving Customers Drug Disposal Options in All CVS Pharmacy Locations

Top of the article

Completes the Installation of 53 Drug Disposal Units Across the State

Company to Introduce In-Home Safe Medication Disposal Solution at No Cost

Dayton, OH Mayor Nan Whaley to Highlight Importance of Proper Drug Disposal

DAYTON, Ohio In its continuing commitment to help build healthier communities, CVS Health (NYSE: CVS) today announced the expansion of its safe medication disposal program, giving customers access to safer, easier and more convenient drug disposal options at every CVS Pharmacy location in Ohio at no cost.

As part of its expanded efforts, the company announced the completed installation of 53 safe medication disposal kiosks in select CVS Pharmacy locations in communities across the state, including Cincinnati, Cleveland, Columbus, Dayton, Toledo and Youngstown, adding to the 29 in-store units previously installed and 38 units donated to local law enforcement. Nationwide, more than 1,700 CVS Pharmacy locations have safe medication disposal and the company has donated more than 990 kiosks to law enforcement. Through this national effort more than 1.1 million pounds of unwanted medication has been collected, including 36,000 pounds in Ohio alone.

CVS Health also announced that beginning in 2020, all CVS Pharmacy locations that do not currently have a safe medication disposal kiosk will offer DisposeRx packets at no cost to patients filling an opioid prescription for the first time. According to the manufacturer, when water and the DisposeRx powder are added to a pill bottle with unwanted prescription medications the combination produces a biodegradable gel, allowing for safe disposal at home.

"When patients leave unused medications especially opioids in a medicine cabinet, there is a risk that those medications might be misused or diverted, which is why we have worked to help increase access to and awareness of safe medication disposal options in the communities we serve," said Jennifer Rudell, District Leader, CVS Health. "Providing more options for the proper disposal of unused medications in our stores and in the home is just one of the ways we're working to help combat opioid misuse across the country."

CVS Health unveiled its safe medication disposal expansion plans, including a commitment to install an additional 1,000 drug disposal kiosks in select CVS Pharmacy locations across the country and donate up to 400 units to law enforcement in 2020, during an event inside a CVS Pharmacy location in Dayton with Mayor Nan Whaley and community health organizations.

"The effort to combat opioid misuse continues across the state of Ohio and nationally," said Dayton, OH Mayor Nan Whaley. "Making sure unused prescription opioids don't end up in the wrong hands is an important step. I commend CVS Health for making it easier for families to get rid of these dangerous and highly addictive drugs in their stores and through in-home disposal kits."

Additionally, nearly 100 CVS Pharmacy locations will join other community sites throughout the country in hosting drug take-back events to further promote the safe disposal of unwanted medication on Saturday, October 26, which marks National Prescription Drug Take-Back Day, a biannual event hosted by the U.S. Drug Enforcement Administration.

CVS Health's commitment to helping prevent and address prescription drug misuse also extends to community education and increasing access to the opioid overdose-reversal drug naloxone.

The company's Pharmacists Teach program brings CVS pharmacists into schools across the country to talk to students and parents about the dangers of prescription drug abuse. More than 500,000 students and parents across the country have participated in the program.

Additionally, CVS Pharmacy has worked with all 50 states, Washington, DC and Puerto Rico to increase access to the opioid overdose-reversal drug naloxone, also known as Narcan. Patients can obtain this potentially life-saving medication, which can reverse the effects of an opioid overdose, without an individual prescription in these states.

To learn more about CVS Health's efforts to combat prescription drug misuse, visit our website.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,800 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 94 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Ian Stanton
860-273-9166
stantoni@aetna.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0
Display Hero
Off
CSR Pillars
Locations
Audience

CVS Health Expands Safe Medication Disposal Program in Wisconsin, Giving Customers Drug Disposal Options in All CVS Pharmacy Locations

Top of the article

Adding Drug Collection Units in 29 CVS Pharmacy Locations Across the State

Company to Introduce In-Home Safe Medication Disposal Solution at No Cost

Attorney General Josh Kaul, Milwaukee County Executive Chris Abele and Take Back My Meds MKE Highlight Importance of Proper Drug Disposal

MILWAUKEE — In its continuing commitment to help build healthier communities, CVS Health (NYSE: CVS) today announced the expansion of its safe medication disposal program, giving customers access to safer, easier and more convenient drug disposal options at every CVS Pharmacy location in Wisconsin at no cost.

As part of its expanded efforts, the company announced the installation of 29 safe medication disposal kiosks in select CVS Pharmacy locations across Wisconsin, adding to the 5 in-store units previously installed and the 48 units donated to local law enforcement. Nationwide, more than 1,700 CVS Pharmacy locations have safe medication disposal and the company has donated more than 990 kiosks to law enforcement. Through this national effort more than 1.1 million pounds of unwanted or expired medication has been collected, including 47,000 pounds in Wisconsin alone.

CVS Health also announced that beginning in 2020, all CVS Pharmacy locations that do not currently have a safe medication disposal kiosk will offer DisposeRx packets at no cost to patients filling an opioid prescription for the first time. According to the manufacturer, when water and the DisposeRx powder are added to a pill bottle with unwanted prescription medications the combination produces a biodegradable gel, allowing for safe disposal at home.

"When patients leave unused medications especially opioids in a medicine cabinet, there is a risk that those medications might be misused or diverted, which is why we have worked to help increase access to and awareness of safe medication disposal options in the communities we serve," said Tom Moriarty, Chief Policy and External Affairs Officer and General Counsel for CVS Health. "Providing more options for the proper disposal of unused medications in our stores and in the home is just one of the ways we're working to help combat opioid misuse across the country."

CVS Health unveiled its safe medication disposal expansion plans, including a commitment to install an additional 1,000 drug disposal kiosks in select CVS Pharmacy locations across the country and donate up to 400 additional units to local police departments in 2020, during an event inside a CVS Pharmacy location in Milwaukee with state, county and local officials and community health organizations.

"The opioid epidemic continues to plague our neighborhoods. By properly disposing of unused medications at drug drop boxes around the state, we can prevent diversion and addiction," said Wisconsin Attorney General Josh Kaul. "I commend everyone who is working to make it easier for families to get rid of unneeded medications."

"Everyone has a role to play in the safety, security and well-being of our community, and drop boxes for unused medicine are a great example of how we can help turn the tide in our fight against the prescription opioid and heroin epidemic in Milwaukee County," said Milwaukee County Executive Chris Abele. "CVS has always been a great community partner, and I want to thank them for providing more places for the safe and proper disposal of unused or expired prescription and over-the-counter medications. The safe disposal of addictive pills in drop boxes not only means they are out of our medicine cabinets when they are no longer needed; it means they are no longer being flushed and at risk of tainting Lake Michigan."

Additionally, nearly 100 CVS Pharmacy locations will join other community sites throughout the country in hosting drug take-back events to further promote the safe disposal of unwanted medication on Saturday, October 26, which marks National Prescription Drug Take-Back Day, a biannual event hosted by the U.S. Drug Enforcement Administration.

"We applaud CVS Pharmacy for providing more options for the proper disposal of unused medications, here in Milwaukee and across the country," said Jon Richards, coalition director of Take Back My Meds MKE. "These programs can help combat prescription drug and opioid misuse and is just one of the ways that organizations like ours are working to help the people of Milwaukee County."

CVS Health's commitment to helping prevent and address prescription drug misuse also extends to community education and increasing access to the opioid overdose-reversal drug naloxone.

The company's Pharmacists Teach program brings CVS pharmacists into schools across the country to talk to students and parents about the dangers of prescription drug misuse. More than 500,000 students and parents across the country have participated in the program.

Additionally, CVS Pharmacy has worked with all 50 states, Washington, DC and Puerto Rico to increase access to the opioid overdose-reversal drug naloxone, also known as Narcan. Patients can obtain this potentially life-saving medication, which can reverse the effects of an opioid overdose, without an individual prescription in all CVS Pharmacy locations nationwide.

To learn more about CVS Health's efforts to combat prescription drug misuse, visit our website.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,800 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 94 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contacts

Joseph Goode
401-770-9820
Joseph.Goode@CVSHealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
Off
CSR Pillars
Locations
Audience

CVS Pharmacy to Offer Safe Medication Disposal Chain-Wide in 2020

Top of the article

Company to add more than 1,000 safe medication disposal units to communities nationwide

Commitment builds on enhanced community-based prevention education, prescriber training and utilization management programs

WOONSOCKET, R.I. — CVS Health (NYSE: CVS) today announced all CVS Pharmacy locations nationwide will offer customers a free safe medication disposal option, beginning in 2020. The company will add 1,000 in-store safe medication disposal units to the more than 1,700 units currently in CVS Pharmacy locations nationwide. It will also donate up to 400 additional units to local police departments, in addition to the more than 990 units already donated to law enforcement. Together, the existing medication disposal units have collected more than 1.1 million pounds of unwanted or expired medications.

Additionally, beginning next year, all CVS Pharmacy locations that do not offer a safe medication disposal kiosk will begin to offer DisposeRx packets at no cost to patients filling an opioid prescription for the first time. According to the manufacturer, when water and the DisposeRx powder are added to a pill bottle with unwanted prescription medications, the combination produces a biodegradable gel, allowing for safe disposal at home.

This Saturday, October 26 is National Prescription Drug Take-Back Day, and nearly 100 CVS Pharmacy locations will join other community sites throughout the country in hosting drug take-back events, to further promote the safe disposal of unwanted medication in coordination with the biannual event hosted by the U.S. Drug Enforcement Administration. And, working with Google Maps, CVS Health is also making it easier for consumers to find year-round medication disposal options at CVS Pharmacy and other locations. Consumers can quickly search "drug drop off near me" in Google Maps to locate permanent disposal locations in their community.

"Our Safe Medication Disposal efforts allow people to easily get rid of unneeded medications including controlled substances at CVS Pharmacy and other locations in their community, getting opioids out of medicine cabinets where they could be diverted or misused," said Thomas Moriarty, Chief Policy and External Affairs Officer, CVS Health. "Providing more options for proper disposal of unused medications in our stores and in the home is just one of the ways we're working to help combat prescription opioid misuse and build healthier communities."

CVS Health's Safe Medication Disposal Program is one of many company initiatives to help address and prevent prescription opioid abuse. CVS Health is also collaborating with Discovery Education, tapping into their expertise in digital curriculum and content, to enhance CVS Health's prescription drug abuse prevention education program, Pharmacists Teach. The program, which has already reached more than 500,000 students and parents across the country, will aim to reach an additional 1.4 million people over three years following this investment.

Additionally, to increase awareness among prescribers about opioid use disorder and non-opioid pain management options, the company's Aetna business unit is offering an Opioid Prescriber Educational Incentive Program. This program will provide financial incentives to physicians, in markets that experience higher rates of opioid use disorder and overdose, to participate in face-to-face educational sessions. In collaboration with the non-profit organization Alosa Health, the sessions share best practices in managing patients with chronic pain as well as patients struggling with addiction. The program will also provide incentives for providers designated as a qualified practitioner to administer medication-assisted therapy under the requirements set out by federal law. This program will begin with select providers in Pennsylvania, Illinois, Maine, West Virginia and Ohio.

The company's prescription benefit management business, CVS Caremark is offering clients the option to limit opioid prescriptions to a three-day supply for pediatric patients with an acute condition who haven't taken opioids before. That's in addition to the existing opioid utilization management strategy offered to CVS Caremark clients, which aligns with the Guideline for Prescribing Opioids for Chronic Pain issued by the U.S. Centers for Disease Control and Prevention (CDC). For clients adopting it, the existing strategy already limits adults with an acute condition who are new to opioid therapy to a 7-day supply.

Finally, CVS Pharmacy patients can now access the opioid overdose-reversal drug naloxone without an individual prescription at every CVS Pharmacy location nationwide, including all 50 states, Washington, D.C., and Puerto Rico. CVS Health has also worked with Google to help people locate naloxone at CVS Pharmacy and other locations in their local community using Google's locator tool.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Erin Shields Britt
Corporate Communications
401-770-9237
Erin.Britt@CVSHealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
9
Display Hero
Off
CSR Pillars
Audience